Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 2,409 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Invasive Procedure Clear all

Conditions: Uterine Fibroids, Uterine Leiomyomata
Interventions: Philips MR guided HIFU system; Device
Lead sponsor: Philips Healthcare; Industry
Eligibility: 18 Years to 59 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Bethesda, Maryland • Houston, Texas

Conditions: Inflammatory Bowel Disease
Interventions: Definity; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy, Spastic Hemiplegic Cerebral Palsy, Spastic Hemiparesis, Spastic Hemiplegia
Interventions: active transcranial direct current stimulation, bimanual training; Device · Behavioral
Lead sponsor: Burke Medical Research Institute; Other
Eligibility: 6 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Depression, Pregnancy Related, Intrapartum Depression
Interventions: Delivery of infrared light to the head, No Infrared treatment; Radiation · Other
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pain Management, Peripheral Neuropathic Pain
Interventions: Cold Pressor Task - Upper Limb, Algometry Pain Tests in the Upper Limb, Algometry Pain Tests in the Lower Limb; Device
Lead sponsor: Evan (Huiliang) Wang; Other
Eligibility: 20 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Coronary Artery Disease
Interventions: MICS CABG, Conventional CABG; Procedure
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • La Crosse, Wisconsin

Conditions: Diabetes Mellitus
Interventions: non-invasive tissue glucose prediction; Device
Lead sponsor: Sciema UG; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Mateo, California

Conditions: ADHD
Interventions: MT1 Auditory startle response patterns analysis algorithm, T.O.V.A. Continuous Performance Test; Device
Lead sponsor: MindTension; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Cognition
Interventions: Behavioral measures, fNIRS Devices & Application, Physiological measures; Behavioral · Device · Other
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Critically Ill
Interventions: Once daily screening, Twice daily screening, PS SBTs, T-piece SBTs; Procedure
Lead sponsor: Unity Health Toronto; Other
Eligibility: 16 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 2
States / cities: Long Beach, California • Atlanta, Georgia

Conditions: Kaposi's Sarcoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parastomal Hernia
Interventions: closure of parastomal hernia fascial defect; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hydration Status
Interventions: Exercise; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Frisco, Texas • Plano, Texas

Conditions: NMIBC
Interventions: Intravesical Recombinant Mycobacterium (rMBCG); Biological
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 9
States / cities: Chandler, Arizona • Sacramento, California • Atlanta, Georgia + 6 more

Conditions: Critical Illness
Interventions: AEGIS (Automated Evaluation of Gastrointestinal Symptoms); Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Cannabis
Interventions: Cannabis(THC) inhaled; Drug
Lead sponsor: ISBRG Corp; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Triple-negative Breast Cancer
Interventions: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody, Placebo, Nab-paclitaxel, Doxorubicin, Cyclophosphamide, Filgrastim, Pegfilgrastim; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 12
States / cities: Palo Alto, California • Norwalk, Connecticut • Carrollton, Georgia + 8 more

Conditions: Bladder Cancer
Interventions: Not listed
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: DLBCL
Interventions: Rituximab Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Procedural Skill Competency
Interventions: Competency based simulation training; Other
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Osteogenesis Imperfecta
Interventions: Manual cuff blood pressure; Procedure
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 1 Year to 35 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Invasive Breast Cancer
Interventions: Cemiplimab, Paclitaxel, Carboplatin (not mandatory), Doxorubicin, Cyclophosphamide; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart Diseases, Myocardial Ischemia
Interventions: cardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication; Procedure · Behavioral · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 5,179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 109
States / cities: Birmingham, Alabama • Yuma, Arizona • Beverly Hills, California + 82 more

Conditions: Cachexia
Interventions: Not listed
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 30 Years to 85 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Galveston, Texas

Search by objective public record fields.

Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography

tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy

Treatment of Intrapartum Depression Using Non-invasive Photobiomodulation

Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

Use of CoG by Patients With Diabetes Mellitus

A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.

Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging

Frequency of Screening and SBT Technique Trial

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Fascial Defect Closure for Minimally Invasive Parastomal Hernia Repair

Wearable Photoplethysmography for Non-invasive Hydration Assessment

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Computer-Aided, Non-Invasive, Acoustic Gastrointestinal Surveillance (AGIS) in ICU Patients

Detection of Cannabis Impairment With ISBRG's SpotLight-THC

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Markers of Response to Intravesical Bladder Cancer Therapy

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

Simulation Training for Ultrasound Guided Central Venous Catheter Insertion

Osteogenesis Imperfecta Blood Pressure Study

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients